Nov. 2019
The Korean name of the corporate is changed
from ‘에이템스’ to ‘에이템즈’.
Headquarter is moved to Munjeong-dong, Songpa-gu, Seoul
Jul. 2019
Series A funding from Hans Biomed Co., Ltd.
Jun. 2019
IND application of “A-Paste-C” to treat cartilage defect
Pre-series A funding by company “B”
May. 2019
Completion of technology transfer of 20 core patents from Ajou University
Apr. 2019
Won the research grant for the Development of Strategic Marine Biomaterials from the Ministry of Oceans and Fisheries
Mar. 2019
Pre-series A funding by VC “H” & “G”
Jan. 2019
Contract with company “K” for the supply of “Acellular cartilage matrix (ACM)”
Nov. 2018
Pre-series A funding by VC “W”
Sep. 2018
IND application of “A-Film-M” (an anti-adhesive) for musculoskeletal injury
Jul. 2018
Pre-series A funding by VC “K”
Jun. 2018
Won the Tech Incubator Program for startups (TIPS) Korea
Pre-series A funding by VC “B”
Certification for Venture Business (Korean Venture Capital Association)
Apr. 2018
NDA for research collaboration with a “B” company in Singapore
R&D Center was established
Jan. 2018
ATEMs is found in Suwon Gwanggyo